4th Quarter - Report

MCDERMOTT WILL & SCHULTE LLP for ROCHE DIAGNOSTICS CORPORATION, INC.

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues affecting FDA regulation of medical devices.

Foreign entity interest: To the extent the U.S. company is affected by activity related to the issues listed above, so too would the foreign parent be affected.

LobbyistCovered position, as disclosed
PAUL WILLIAM RADENSKY —
SHEILA D WALCOFF Committee, U.S. House of Representatives
ERIC ZIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.